Reactome Pathway Database

Schema > ProteinDrug > Entries

alunacedase alfa [extracellular region] Show undefined attributes

compartment

[Compartment:984] extracellular region

created [InstanceEdit:9707766] Jassal, Bijay, 2020年11月20日

crossReference

[DatabaseIdentifier:11944911] Mondo:0005091

dbId 9707803

disease

[Disease:9678120] severe acute respiratory syndrome

displayName alunacedase alfa [extracellular region]

inDisease true

literatureReference

[LiteratureReference:9707809] A pilot clinical trial of recombinant human angiotensin-converting enzyme 2 in acute respiratory distress syndrome
[LiteratureReference:9707836] Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2
[LiteratureReference:9707794] Human recombinant soluble ACE2 (hrsACE2) shows promise for treating severe COVID-19
[LiteratureReference:9707801] Human recombinant soluble ACE2 in severe COVID-19

maxDepth 1

memberOf

[DefinedSet:R-ALL-9707798] Spike inhibitors [extracellular region]

name

alunacedase alfa
hrsACE2
human recombinant soluble ACE2

referenceEntity [ReferenceTherapeutic:iuphar.ligand:11320] alunacedase alfa [Guide to Pharmacology:11320]

schemaClass ProteinDrug

stId R-ALL-9707803

Referrals

(hasMember)

[DefinedSet:R-ALL-9707798] Spike inhibitors [extracellular region]

© 2025 Reactome

Cite Us!